MLTX

MoonLake Immunotherapeutics Class A Ordinary Shares

16.20

USD

MLTX Earnings Reports

Positive Surprise Ratio

MLTX beat 8 of 14 last estimates.

57%

Next Report

Date of Next Report

Feb 26, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$1.00

Implied change from Q3 25 (Revenue/ EPS)

-9.09%

Implied change from Q4 24 (Revenue/ EPS)

+38.89%

MoonLake Immunotherapeutics Class A Ordinary Shares earnings per share and revenue

On Nov 05, 2025, MLTX reported earnings of -1.10 USD per share (EPS) for Q3 25, missing the estimate of -0.89 USD, resulting in a -22.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.54% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 18 analysts forecast an EPS of -1.00 USD, with revenue projected to reach -- USD, implying an decrease of -9.09% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were MoonLake Immunotherapeutics Class A Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, MoonLake Immunotherapeutics Class A Ordinary Shares reported EPS of -$1.10, missing estimates by -22.75%, and revenue of $0.00, 0% as expectations.

How did the market react to MoonLake Immunotherapeutics Class A Ordinary Shares's Q3 2025 earnings?

The stock price moved up 4.54%, changed from $10.13 before the earnings release to $10.59 the day after.

When is MoonLake Immunotherapeutics Class A Ordinary Shares expected to report next?

The next earning report is scheduled for Feb 26, 2026.

What are the forecasts for MoonLake Immunotherapeutics Class A Ordinary Shares's next earnings report?

Based on 18 analysts, MoonLake Immunotherapeutics Class A Ordinary Shares is expected to report EPS of -$1.00 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.